Trial intelligence / Profile preview

Patiromer Titration in Heart Failure Patients With CKD

NCT01130597Phase 2Completed

Sponsor
Relypsa, Inc.
Start
May 2010
Primary completion
Sep 2010
Modality
Polymer-based Nanoparticles, Small Molecules
Countries
2
01

Overview

A Phase 2 trial of patiromer in hyperkalemia, sponsored by Relypsa, Inc.. Started May 2010; status: completed.

02

Drugs

patiromer
03

Conditions

hyperkalemia

Beyond the preview

Go deeper on NCT01130597.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01130597.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call